iShares JPMorgan USD Emerging Markets Bond ETF vs Lemonade Inc — how do they compare? iShares JPMorgan USD Emerging Markets Bond ETF trades at $91.05 (market cap $12.87B), while Lemonade Inc trades at $46.71 (market cap $3.63B). The key difference: iShares JPMorgan USD Emerging Markets Bond ETF is far larger — about 3.5× Lemonade Inc's market cap, and iShares JPMorgan USD Emerging Markets Bond ETF is more actively traded (14,946,002 versus 1,544,794). Which is the better fit depends on your goals — on Pluang, investors hold iShares JPMorgan USD Emerging Markets Bond ETF for 50 Days and Lemonade Inc for 27 Days on average.
| EMB | LMND | |
|---|---|---|
Market Cap | $12.87B | $3.63B |
Volume | 14,946,002 | 1,544,794 |
Sector | Fixed Income | Financials |
52-Week High | $97.74 | $96.57 |
52-Week Low | $90.14 | $43.91 |
Typical Hold Time | 50 Days | 27 Days |
Enterprise Value | — | $3.49B |
Signals from Pluang's Aura AI — not financial advice
EMB trades at $90.96 with minimal daily movement (+0.2%), showing technical bearish signals from moving averages while oscillators remain neutral. The stock faces resistance at $91-92 with support at $90. Recent dividend declarations of $0.41-0.44 per share provide income appeal, though key financial ratios remain undisclosed in current data.
The outlook appears cautious with technical indicators signaling bearish momentum. Income-focused investors may find value in the dividend yield, but limited fundamental data availability and bearish technical signals suggest careful evaluation is warranted. Market risks include broader economic pressures affecting bond yields and emerging market exposure.
Lemonade (LMND) trades at $46.83, up 1.14% on the day, with a bearish technical signal despite recent earnings beats. Revenue growth is accelerating, reaching $738M in 2025, with a narrowing net loss margin from -116% in 2022 to -22.4% in 2025. The company is expanding geographically and product-wise, supported by AI-driven efficiency, targeting EBITDA profitability by late 2026.
The outlook is mixed: strong growth and path to profitability present opportunity, but persistent losses, high valuation multiples, and bearish technicals pose risks. The consensus price target of $67 implies significant upside if execution continues, but investor sentiment remains divided given the stock's high volatility and unprofitability.
Trailing returns across standard periods
Latest headlines on both assets
EMB invests in U.S. dollar-denominated sovereign debt from emerging market countries. It provides exposure to government bonds from dozens of nations like Turkey, Mexico, and Brazil, offering a way to seek higher yields and geographic diversification.
Read more on EMB →Lemonade Inc operates in the insurance industry. The company offers digital and artificial intelligence based platform for various insurances and for settling claims and paying premiums. The platform ensures transparency in issuing policies and settling disputes.
Read more on LMND →